A multifunctional antimicrobial peptide with cell-penetrating and β-lactam-potentiating activities for combating methicillin-resistant Staphylococcus aureus and carbapenem-resistant Enterobacteriaceae infections
Drug Resistance Updates · 2026
DOI: 10.1016/j.drup.2026.101450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Resistance Updates, 2026. Verfasst von Xiaoxiao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shaanxi Key Laboratory of Agricultural and Environmental Microbiology, College of Life Sciences, Northwest A&F University, Yangling, China. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Carbapenem-Resistant Enterobacteriaceae, Anti-Bacterial Agents, beta-Lactams. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Institute of Microbiology, Chinese Academy of Sciences, Guangxi University, National Natural Science Foundation of China.
Abstract (Originalsprache)
AIMS: The global health crisis posed by New Delhi metallo-β-lactamase-producing carbapenem-resistant Enterobacteriaceae (NDM-CRE) and methicillin-resistant Staphylococcus aureus (MRSA) underscores the urgent need for novel antimicrobial agents. Natural antimicrobial peptides (AMPs) often suffer from limited modes of action, narrow antimicrobial spectra, and poor cellular permeability. To address these challenges, we engineered X1-3, a rationally designed AMP that exhibits direct bactericidal activity, efficient cell penetration and synergistic potentiation of β-lactams. METHODS: X1-3 was generated via structure-activity relationship-guided optimization and machine learning-assisted screening, followed by characterization of its physicochemical properties and safety profile. Its antimicrobial and β-lactam synergistic activities were evaluated against clinical NDM-CRE and MRSA isolates using checkerboard assays, time-kill kinetics, and confocal microscopy. Mechanistic studies combined transcriptomic profiling with flow cytometry, gel retardation, and enzymatic assays to elucidate multimodal actions involving membrane disruption, DNA binding, and specific inhibition of NDM-5 and PBP2a. Intracellular penetration and in vivo therapeutic potential were assessed in RAW264.7 macrophage infection model and murine systemic infection model, respectively. RESULTS: X1-3 exhibits high stability and robust activity against NDM-CRE, MRSA, and vancomycin-resistant Enterococcus, with low resistance induction. Additionally, X1-3 shows a robust anti-virulence profile by inhibiting biofilm formation and eradicating mature biofilms in both NDM-CRE and MRSA. Mechanistic studies revealed that X1-3 induces bacterial death primarily through membrane disruption and multiple synergistic mechanisms (DNA binding and metabolic perturbations). As a β-lactam adjuvant, X1-3 enhances antibiotic efficacy by disrupting proton motive force (PMF) to suppress efflux pumps and directly targeting NDM-CRE- and MRSA-associated resistance enzymes, including NDM and penicillin-binding protein 2a (PBP2a). Furthermore, it penetrates host cells via lipid raft-mediated internalization to eradicate intracellular pathogens and attenuate inflammation. In vivo, the combination of X1-3 with β-lactam antibiotics showed promising therapeutic potential with no observable systemic toxicity. Notably, the treatment effectively alleviated the MRSA-infected wound. CONCLUSIONS: Rational structural optimization enables X1-3 to function as both a direct bactericide and a β-lactam adjuvant. This dual strategy significantly improves efficacy against clinical NDM-CRE and MRSA, offering a novel therapeutic paradigm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shaanxi Key Laboratory of Agricultural and Environmental Microbiology, College of Life Sciences, Northwest A&F University, Yangling, China.
- Shaanxi Key Laboratory of Agricultural and Environmental Microbiology, College of Life Sciences, Northwest A&F University, Yangling, China. Electronic address: xulei@nwafu.edu.cn.
- Shaanxi Key Laboratory of Agricultural and Environmental Microbiology, College of Life Sciences, Northwest A&F University, Yangling, China. Electronic address: xihuishen@nwsuaf.edu.cn.
Förderung
- Institute of Microbiology, Chinese Academy of Sciences
- Guangxi University
- National Natural Science Foundation of China
Zitieren
APA
Zhang, X., Zhang, Y., Zhang, X., Li, W., Hou, Y., Wang, Y., Xu, L., & Shen, X. (2026). A multifunctional antimicrobial peptide with cell-penetrating and β-lactam-potentiating activities for combating methicillin-resistant Staphylococcus aureus and carbapenem-resistant Enterobacteriaceae infections. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2026.101450
Vancouver
Zhang X, Zhang Y, Zhang X, Li W, Hou Y, Wang Y, et al. A multifunctional antimicrobial peptide with cell-penetrating and β-lactam-potentiating activities for combating methicillin-resistant Staphylococcus aureus and carbapenem-resistant Enterobacteriaceae infections. Drug Resistance Updates. 2026. doi:10.1016/j.drup.2026.101450
BibTeX
@article{Zhang2026,
author = {Zhang, Xiaoxiao and Zhang, Yuxin and Zhang, Xiaoxue and Li, Wenshuai and Hou, Yixin and Wang, Yao and Xu, Lei and Shen, Xihui},
title = {A multifunctional antimicrobial peptide with cell-penetrating and β-lactam-potentiating activities for combating methicillin-resistant Staphylococcus aureus and carbapenem-resistant Enterobacteriaceae infections},
journal = {Drug Resistance Updates},
year = {2026},
doi = {10.1016/j.drup.2026.101450}
}
EUVIMED